OC Business Journal

Diality, a maker of hemodialysis machines, adds chief business officer

By Jessie Yount | yount@ocbj.com

Diality Inc., an Irvine developer of an inhome hemodialysis machine, has added Dan Guthrie as chief business officer. Guthrie was most recently chief commercial officer at Pennsylvania-based Neuronetics Inc. (Nasdaq: STIM), where he led the company’s commercial expansion efforts following its initial public offering in 2018. The company, which focuses on psychiatric disorders, reported 2020 revenue of $49.2 million; last week, it had a $373 million market cap. He has held senior roles at Novanta, Zimmer Biomet, Medtronic, and Fleet Laboratories.

“I am thrilled to be joining the Diality team during this next, crucial stage of its development as we finalize our go-to market strategy for the company,” Guthrie said.

“Today, the United States alone spends over $50 billion annually to treat over 600,000 dialysis patients and that number is at pace to grow to nearly 800,000 patients by 2030. Given changes to Medicare reimbursement, our technology offers significant potential to provide value to patients, providers, and payers as the category evolves from a volume to a value-based care model over the next decade.”

In-home dialysis is often overlooked because the machinery is difficult to manage. Diality says it’s designing a machine that automates setup and daily use so that patients feel comfortable using in-home treatments without the need for pre-mixed dialysate bags or external water treatment.

The company has raised $59.5 million in funding since its 2014 inception and has over 30 employees. ■

TABLE OF CONTENTS

en-us

2021-07-19T07:00:00.0000000Z

2021-07-19T07:00:00.0000000Z

https://ocbusinessjournal.pressreader.com/article/281844351647246

LABJ